Type 2 diabetes mellitus is a chronic metabolic disorder that results from defects in both
insulin secretion and insulin action. An elevated rate of basal hepatic glucose production in …

People with type 2 diabetes form a heterogeneous group. Consequently, treatment
regimens and therapeutic targets should be individualized. The treatment of type 2 diabetes …

Despite exhaustive efforts to better manage patients with type 2 diabetes mellitus (formerly
known as non-insulin-dependent diabetes mellitus), attempts at maintaining near normal …

As people with type 2 diabetes form a heterogeneous group, treatment regimens and
therapeutic targets should be individualized. As type 2 diabetes is characterized by insulin …

Type 2 diabetes mellitus is a chronic metabolic disorder associated with high morbidity and
mortality from long-term microvascular and macrovascular complications. Evidence from …

Description: The American College of Physicians (ACP) developed this guideline to present
the evidence and provide clinical recommendations on oral pharmacologic treatment of type …

Key Clinical Points Glycemic Control in Type 2 Diabetes Mellitus Intensive glycemic control
reduces the risk of microvascular complications of type 2 diabetes, but the effect of strict …

This article has been corrected. The original version (PDF) is appended to this article as a
supplement. Description: The American College of Physicians (ACP) developed this …

The article focuses on the major classes of oral agents used to treat type 2 diabetes with an
emphasis on the benefits and risks of each class. It states that there are more therapeutic …

IN BRIEF The paradigms for oral pharmacological therapy in type 2 diabetes are shifting as
we attain new insights into the optimal metabolic control in our patients. Each drug category …